Pulmonx Corporation (LUNG)
LUNG Stock Price Chart
Explore Pulmonx Corporation interactive price chart. Choose custom timeframes to analyze LUNG price movements and trends.
LUNG Company Profile
Discover essential business fundamentals and corporate details for Pulmonx Corporation (LUNG) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
1 Oct 2020
Employees
291.00
Website
https://pulmonx.comCEO
Steven S. Williamson
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
LUNG Financial Timeline
Browse a chronological timeline of Pulmonx Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 17 Feb 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is -$0.40, while revenue estimate is $20.78M.
Earnings released on 30 Jul 2025
EPS came in at -$0.38 surpassing the estimated -$0.40 by +5.00%, while revenue for the quarter reached $23.86M , beating expectations by +1.99%.
Earnings released on 30 Apr 2025
EPS came in at -$0.36 surpassing the estimated -$0.37 by +2.70%, while revenue for the quarter reached $22.54M , beating expectations by +2.29%.
Earnings released on 19 Feb 2025
EPS came in at -$0.33 surpassing the estimated -$0.45 by +26.67%, while revenue for the quarter reached $23.77M , beating expectations by +6.61%.
Earnings released on 30 Oct 2024
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $20.39M , missing expectations by -8.55%.
Earnings released on 31 Jul 2024
EPS came in at -$0.39 surpassing the estimated -$0.41 by +4.88%, while revenue for the quarter reached $20.78M , beating expectations by +3.24%.
Earnings released on 1 May 2024
EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $18.85M , beating expectations by +5.39%.
Earnings released on 21 Feb 2024
EPS came in at -$0.36 surpassing the estimated -$0.39 by +7.69%, while revenue for the quarter reached $19.28M , beating expectations by +5.52%.
Earnings released on 30 Oct 2023
EPS came in at -$0.39 surpassing the estimated -$0.45 by +13.33%, while revenue for the quarter reached $17.67M , beating expectations by +7.80%.
Earnings released on 2 Aug 2023
EPS came in at -$0.43 matching the estimated -$0.43, while revenue for the quarter reached $17.19M , beating expectations by +8.41%.
Earnings released on 2 May 2023
EPS came in at -$0.42 surpassing the estimated -$0.43 by +2.33%, while revenue for the quarter reached $14.54M , beating expectations by +7.75%.
Earnings released on 22 Feb 2023
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%, while revenue for the quarter reached $15.43M , beating expectations by +10.35%.
Earnings released on 3 Nov 2022
EPS came in at -$0.38 surpassing the estimated -$0.40 by +5.00%, while revenue for the quarter reached $13.50M , missing expectations by -9.59%.
Earnings released on 2 Aug 2022
EPS came in at -$0.40 surpassing the estimated -$0.41 by +2.44%, while revenue for the quarter reached $13.95M , beating expectations by +1.31%.
Earnings released on 3 May 2022
EPS came in at -$0.43 falling short of the estimated -$0.37 by -16.22%, while revenue for the quarter reached $10.79M , beating expectations by +16.44%.
Earnings released on 23 Feb 2022
EPS came in at -$0.35 matching the estimated -$0.35, while revenue for the quarter reached $13.71M , missing expectations by -3.75%.
Earnings released on 2 Nov 2021
EPS came in at -$0.28 surpassing the estimated -$0.37 by +24.32%, while revenue for the quarter reached $13.26M , beating expectations by +0.61%.
Earnings released on 3 Aug 2021
EPS came in at -$0.34 surpassing the estimated -$0.38 by +10.53%, while revenue for the quarter reached $12.20M , meeting expectations.
Earnings released on 4 May 2021
EPS came in at -$0.34 surpassing the estimated -$0.39 by +12.82%, while revenue for the quarter reached $9.24M , missing expectations by -9.52%.
Earnings released on 2 Mar 2021
EPS came in at -$0.27 surpassing the estimated -$0.28 by +3.57%, while revenue for the quarter reached $9.83M .
Earnings released on 10 Nov 2020
EPS came in at -$1.37 surpassing the estimated -$5.46 by +74.91%, while revenue for the quarter reached $10.61M , missing expectations by -33.98%.
LUNG Stock Performance
Access detailed LUNG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.